Teladoc Health Names Technology Leader Claus Jensen as Chief Innovation Officer
April 26, 2021 at 09:00 AM EDT
PURCHASE, NY, April 26, 2021 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, has named Claus Jensen as chief innovation officer to lead the research and development team. With more than 20 years of experience leading digital transformation at enterprise healthcare and technology organizations, Jensen has successfully built and scaled teams across product innovation, information systems, health informatics and data products.
“We are excited to welcome Claus to the Teladoc Health team to lead our innovation efforts,” said Jason Gorevic, Teladoc Health chief executive officer. “With deep experience transforming hospital systems and health plans, Claus is the right leader at the right time to accelerate Teladoc Health’s vision of connecting the healthcare experience from hospital to home.”
Jensen joins Teladoc Health from Memorial Sloan Kettering Cancer Center (MSK), where he served as chief digital officer and head of technology. At MSK, he oversaw the integration of data and technology resources, enabling the organization to better meet critical care and research objectives. Prior to that, Jensen held transformational leadership roles at Danske Bank, IBM and as chief technology officer of CVS Health-Aetna. During his time at IBM, he was a trusted advisor on business and IT transformation journeys for many of the Fortune 100 companies.
“Having grown up with a family full of healthcare professionals, I have always recognized the importance of personalized and accessible healthcare experiences,” said Jensen, Teladoc Health chief innovation officer. “Teladoc Health continues to leverage technology and data insights and deliver on the promise of whole-person virtual care by providing access to high-quality and personalized care anywhere.”
For more information, visit www.teladochealth.com/leadership.
About Teladoc Health
Teladoc Health Media Contact:
Teladoc Health Investor Contact: